Pilot Open-label Trial of Nivolumab Combined With Chemotherapy in Refractory Myelodysplastic Syndromes.
Phase of Trial: Phase I/II
Latest Information Update: 29 Aug 2017
At a glance
- Drugs Nivolumab (Primary) ; Azacitidine; Cyclophosphamide; Cytarabine; Fludarabine; Melphalan; Sildenafil
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 29 Aug 2017 New trial record